Ma,et al.Adjuvant PD-1 blockade with camrelizumab in high-(DIPPER): A multicenter, open-label, phase
助力慢乙肝的精准化治疗,进一步提高临床治愈率。参考文献: Pfefferkorn M, Handrick S, Maier M, et al. High levels of anti--2
treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody)-high/mismatch repair